This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Yazaki, M. Articles by Benson, M. D. Search for Related Content PubMed PubMed Citation Articles by Yazaki, M. Articles by Benson, M. D.

(American Journal of Pathology. 2001;158:227-233.)
© 2001 American Society for Investigative Pathology

Regular Articles

Biochemical Characterization of a Neuroserpin Variant Associated with Hereditary Dementia

From the Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, Indiana

Neuroserpin isolated from inclusion bodies in the brain of a patient with a neurodegenerative disease was characterized biochemically. The protein consisted of residues 20 to 410 of the neuroserpin precursor deduced from its cDNA sequence indicating the entire molecule was deposited. A minor amount started with residue 19 of the precursor, and the carboxyl terminus was heterogeneous ending at residues 405, 407, 409, and 410. Arg was present at position 52. No normal Ser52 was found indicating that only mutant neuroserpin was present in the inclusion bodies. The three potential Asn glycosylation sites all contained carbohydrate. DNA sequence analysis of exons 2 to 9 of the neuroserpin gene in the proband showed the published normal neuroserpin sequence except for the presence of both adenine and cytosine at the first position of codon 52, that indicates heterozygosity for both the normal Ser(AGT) and variant Arg(CGT) at this position in the expressed protein. Restriction fragment length polymorphism analysis of a polymerase chain reaction product from exon 2 revealed the propositus and his affected sibling both were heterozygous for the mutation whereas 100 unaffected controls were negative. Chemical characterization of the variant neuroserpin will significantly enhance the understanding of this protein in both normal physiology and neurodegenerative diseases.

This article has been cited by other articles:

				I. Gourfinkel-An, C. Duyckaerts, A. Camuzat, C. Meyrignac, P. Sonderegger, M. Baulac, and A. Brice Clinical and neuropathologic study of a French family with a mutation in the neuroserpin gene Neurology, July 3, 2007; 69(1): 79 - 83. [Abstract] [Full Text] [PDF]

				G. Galliciotti, M. Glatzel, J. Kinter, S. V. Kozlov, P. Cinelli, T. Rulicke, and P. Sonderegger Accumulation of Mutant Neuroserpin Precedes Development of Clinical Symptoms in Familial Encephalopathy with Neuroserpin Inclusion Bodies Am. J. Pathol., April 1, 2007; 170(4): 1305 - 1313. [Abstract] [Full Text] [PDF]

				E. Miranda, K. Romisch, and D. A. Lomas Mutants of Neuroserpin That Cause Dementia Accumulate as Polymers within the Endoplasmic Reticulum J. Biol. Chem., July 2, 2004; 279(27): 28283 - 28291. [Abstract] [Full Text] [PDF]

				A. Makarova, I. Mikhailenko, T. H. Bugge, K. List, D. A. Lawrence, and D. K. Strickland The Low Density Lipoprotein Receptor-related Protein Modulates Protease Activity in the Brain by Mediating the Cellular Internalization of Both Neuroserpin and Neuroserpin-Tissue-type Plasminogen Activator Complexes J. Biol. Chem., December 12, 2003; 278(50): 50250 - 50258. [Abstract] [Full Text] [PDF]

				D. Gveric, B. Herrera, A. Petzold, D. A. Lawrence, and M. L. Cuzner Impaired fibrinolysis in multiple sclerosis: a role for tissue plasminogen activator inhibitors Brain, July 1, 2003; 126(7): 1590 - 1598. [Abstract] [Full Text] [PDF]

				D. Belorgey, D. C. Crowther, R. Mahadeva, and D. A. Lomas Mutant Neuroserpin (S49P) That Causes Familial Encephalopathy with Neuroserpin Inclusion Bodies Is a Poor Proteinase Inhibitor and Readily Forms Polymers in Vitro J. Biol. Chem., May 3, 2002; 277(19): 17367 - 17373. [Abstract] [Full Text] [PDF]